The scrip opened at Rs. 785 and has touched a high and low of Rs. 799.1 and Rs. 785 respectively.
Aurobindo Pharma Ltd has received US FDA approval for Bupivacaine Hydrochloride Injection.
Aurobindo Pharma Ltd is currently trading at Rs. 793.5, up by Rs. 7.45 or 0.95% from its previous closing of Rs. 786.05 on the BSE.
Aurobindo Pharma Ltd is currently trading at Rs. 793.5, up by Rs. 7.45 or 0.95% from its previous closing of Rs. 786.05 on the BSE.
The scrip opened at Rs. 785 and has touched a high and low of Rs. 799.1 and Rs. 785 respectively. So far 400661(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 45997.26 crore.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 891.5 on 30-Dec-2015 and a 52 week low of Rs. 582 on 25-Feb-2016. Last one week high and low of the scrip stood at Rs. 823.55 and Rs. 781.75 respectively.
The promoters holding in the company stood at 53.79 % while Institutions and Non-Institutions held 34.67 % and 11.54 % respectively.
The stock is currently trading above its 200 DMA.
Great Article! Thanks for sharing valuable Information.....
ReplyDeleteBest BUY or SELL Stocks
Stock Market News
New Mutual Funds
Upcoming IPOs
Did You Know StockMarket